Feb 26, 2018 - The biotech should receive more good news in 2018. But will it be good enough to justify Alnylam's steep valuation?
Mar 01, 2018 - The biotech has two drugs under regulatory review, and a pipeline of 45 drugs advancing towards commercialization.
Mar 03, 2018 - These biotech stocks have surged to nosebleed valuations. Here's why.
Mar 05, 2018 - The following slide deck was published by Ionis Pharmaceuticals, Inc. in conjunction with this event.
Mar 14, 2018 - The biotech has a lot of promise -- but some big risks.
Mar 15, 2018 - News of a major transaction between these two companies sends their stock prices in opposite directions.
Mar 22, 2018 - Which of these big biotech stocks is the better pick right now?
Mar 24, 2018 - The biotech has plenty of potential -- but plenty of risk.
Mar 26, 2018 - The following slide deck was published by Ion Beam Applications S.A. in conjunction with their 2017 Q4 earnings call.
Apr 02, 2018 - Here's how a pretty good day for Pfizer ruined Alnylam's entire holiday weekend.